Medical network, June 12, our country is the abuse of antibiotics is the most serious country in the world, global antibiotic usage is 13 g per capita every year, and our country is 138 g. Every year in the face of serious abuse of antibiotics, China promulgated a series of resistance to limit, the limit infusion reform actively, omni-directional linkage control antibiotic use, curb unreasonable medical behavior. What about the 2016 antibiotic market performance?
▍ resistance to limit the rising, is still difficult to market growth suppression
As early as in 2012, "the most severe in the history of resistance to limit has been on the stage, the health development planning commission issued the measures for the management of clinical use of antimicrobial agents due to put forward three measures for the administration of antibiotics, severe punishment in violation of the doctor.
In 2015, the health and family planning commission issued a notice of further restrictions on the use of antibiotics by doctors. This resistance limit is put forward and hospital performance, doctors limit its ChuFangQuan to abuse of antibiotics, hospital responsibility clear, further upgrade the "history's most severe resistance limit.
In 2016, the state development planning commission, the national development and reform commission and other 14 departments jointly issued "containing bacteria resistant national action plan (2016-2020)", put forward to 2020, the retail pharmacies on prescription sales antimicrobials to achieve full coverage. Many provinces have completely halted the delivery of hospital clinics.
After limit big hospital outpatient infusion, the most severe resistance limit extension to the grassroots, in March 2017, the national health development planning commission issued "about further strengthen the management of clinical application of antibacterial drugs contain bacteria resistant notice, the key supervision primary care, and request a month of the nation's medical institutions formulated agencies at various levels of antimicrobial drug supply catalog, clear all levels of physicians ChuFangQuan antibacterial drugs, and report to the local health bureau for the record.
The trend of Chinese restrictions is clear: not the strictest, only stricter. The data are also starting to show up in the market.
Monitoring shows that the drugs market, though seemingly falling in a short period of time did not have a bluff type, still maintain a certain growth, but growth has been slowing, retail terminal has fell.
In 2016, the national antibiotic and synthetic antimicrobial drug only increased by 5.8 per cent to 183.1 billion yuan in hospital and retail sales. Among them, the level of the hospital overall market share has no obvious change, top ten brand retail pharmacies antibiotics and synthetic antimicrobial generated sales of 10.841 billion yuan, the market share of 5.39%, a slight decline in 2015.
2013-2016 antibiotics and synthetic antimicrobial grade hospitals and retail terminal sales ($100 million)
Antibiotics and synthetic antimicrobial production enterprise market share TOP 10
According to the data, the share of antibiotics and synthetic antimicrobial production companies in grade hospitals and retail terminals accounted for 82.31 percent, while foreign companies accounted for 17.69 percent. From antibiotics and synthetic antimicrobials list view, the top ten enterprise wide medicine baiyun mountain, Harbin pharmaceutical group, its group, for two consecutive years ranks the first three top ten pharmaceutical companies to dominate, the share of state-owned enterprises in Pfizer alone foreign seats, ranked ninth.
▍ cephalosporins leading level hospital
Cephalosporin and penicillin, beta-lactase inhibitors are all beta-lactamide antibiotics. In 2017 the national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue, compound beta lactamase inhibitor drugs have amoxicillin clavulanic acid, for card Westwood clavulanic acid potassium, sodium amoxicillin shu temple, ampicillin sodium shu ba, and mezlocillin sodium shu ba jotham, sodium piperacillin sodium shu ba, piperacillin he azole sodium and other seven drugs.
Class of antibiotics and antimicrobial subclass hospitals and retail terminal sales ($100 million)
In 2016, sales of beta-lactase inhibitors fell slightly. Among them, cephalospores lead the room.
Cephalospores have long been a type of antibiotic used in the country. According to the CCMH monitoring data, cephalosporin sales at grade hospitals and retail terminals were 98.956 billion yuan, accounting for more than half of antibiotics and synthetic antimicrobials.
Cephalosporins and cephalothin, is a kind of broad spectrum semisynthetic antibiotics, its huge "family", now has developed into the fifth generation cephalosporin class, a total of 1549 kinds of cephalosporin drugs, which is known generically as 47, market competition is intense.
Of the top 10 hospitals in the county, eight were cephalospores. Six of the 10 brands in the city's ranking hospitals are cephalospores. Cephalosporins sulfur amidine namely pioneer 18 at the city level and county level are the top three, five water cefazolin sodium China resources only a production enterprise, the size of the market stability, ranked second in the city level and county level.
Antibiotic and synthetic antimicrobial county level hospital TOP10 brand share
Antibiotic and synthetic antimicrobial city level hospital TOP10 brand share
In 2016, according to the monitoring, to the city level hospital antibiotic sales sulfur amidine, cephalosporin in cephalosporin class share is 6.51%, total market share of nearly 90% in the first three producers, wide medicine baiyun mountain maintain leading position, accounted for 65.83%. The injection is used for the respiratory system, liver bile system, five officials, urinary tract infection and endocarditis and sepsis.
Ceftiamidine producer market share TOP 3
A slight drop in ▍ retail end
In 2016, the state development planning commission, the national development and reform commission and other 14 departments jointly issued "containing bacteria resistant national action plan (2016-2020)", put forward to 2020, the retail pharmacies on prescription sales antimicrobials to achieve full coverage. Provincial (district, city) the proportion that sells antibacterial medicine by veterinary prescription is 50%. This means that the retail market will fully implement the prescription of antibiotics.
What about the sales of antimicrobials in retail pharmacies in 2016?
According to the monitoring, compared to the city level hospital and county level hospitals are on the rise, retail pharmacies antibiotics and synthetic antimicrobial generated sales of 10.841 billion yuan, a 5.39% market share, a slight decline in 2015.
From the product, the product of penicillin oral preparation is numerous, and the sales in retail pharmacies are larger than those of cephalospores.
Penicillin is the second largest category of antibiotics. In 2016, penicillin accounted for 16.39 per cent of the market, down from 16.77 per cent in 2015. Among them, the total sales of three products including piperazolin, amoxiclinic acid and piperazolin are 15 billion yuan.
Antibiotics and synthetic antibacterial retail pharmacy TOP 10 brand share
For retail pharmacy prescription drugs may need sales growth, competition is intense, need similar products is concentrated in the penicillin and cephalosporin, big ring inside lipid three types of antibiotics, four of them amoxicillin capsule, 4 for the formulation of cefixime, the rest two for azithromycin preparations. In 2016, the sales of amoxicillin capsules were 17.86 billion yuan, a year-on-year increase of 0.9 percent.
Amoxicillin capsule TOP 3 (retail pharmacies)
Amoxicillin capsule manufacturer home, the federal pharmaceutical, Harbin pharmaceutical group, nolato, sales ranks in the first three, overall fell by about 4%, the market share of 24.58%, 16.08% and 15.16% respectively.
|
